OPPOSITION PENDING
on 04 Dec 2024
Last Applicant/ Owned by
101 South St., Suite 400
Somerville
MA
02143
Serial Number
98297806 filed on 04th Dec 2023
Registration Number
N/A
Correspondent Address
CHRISTINA M. LICURSI
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
SAIL
Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; research and development in the field of computational biology, biotechnology and pharmaceuticals Pharmaceutical preparations for use in gene therapy; biological and pharmaceutical preparations, both comprised of therapeutic nucleic acids, namely RNA, for the treatment and prevention of genetic disease Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; research and development in the field of computational biology, biotechnology and pharmaceuticals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for use in gene therapy; biological and pharmaceutical preparations, both comprised of therapeutic nucleic acids, namely RNA, for the treatment and prevention of genetic diseases and disorders, genomic diseases and disorders, cancer, infectious diseases, and immune system related diseases and disorders; Therapeutic preparations to modulate metabolism; pharmaceutical preparations and agents to modulate metabolism; pharmaceutical agents that modulate metabolism for scientific and research use; therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98297806
Mark Type
No Service/Collective Mark
Attorney Docket Number
No V03392000500
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 04th Dec 2024 | OPPOSITION INSTITUTED NO. 999999 |
| 04th Dec 2024 | OPPOSITION PAPERS RECEIVED AT TTAB |
| 05th Nov 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 05th Nov 2024 | PUBLISHED FOR OPPOSITION |
| 16th Oct 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 26th Sep 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 25th Sep 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 25th Sep 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 25th Sep 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 02th Jul 2024 | ASSIGNED TO EXAMINER |